We describe here a hemoglobin adduct assay applied to an analysis of samples from smokers and nonsmokers. The assay includes a sensitive method for quantification of orthotoluidine 2-aminonaphthylene, and 3-and 4-aminobiphenyl hemoglobin adducts in human blood using capillary gas chromatographytandem mass spectrometry. Basic hydrolysis and derivatization with pentafluoropropionic acid anhydride are followed by programmable temperature vaporization and pseudo on-column capillary gas chromatography with positive electron ionization tandem mass spectrometry analysis. Standard deviation of calibration curves (n = 6) shows that the limits of detection for o-toluidine, 2-aminonaphthylene, and 3-and 4-aminobiphenyl were 0.23, 0.39, 0.30, and 0.24 pg total on-column, respectively. The effective working limit of detection is estimated at approximately 5.22 pg/g Hb and 18.73 pg/g Hb for 4-aminobiphenyl and 2-aminonaphthylene, respectively. In a group that was predominately male and African-American, the level of 4-aminobiphenyl Hb adducts was significantly different between smokers and nonsmokers. Among 93 nonsmokers with serum cotinine concentrations less than 10 ng/mL, the geometric mean (95% CI) concentration of 4-aminobiphenyl was 29.9 pg/g hemoglobin (Hb; 29.4 to 30.4). Conversely, in 100 smokers the 4-aminobiphenyl adducts geometric mean concentration was significantly greater at 73.0 pg/g Hb (72.6 to 73.4). 4-Aminobiphenyl hemoglobin adduct and serum cotinine concentrations were correlated (r = 0.496; p < 0.0001; n = 193). In 15% of smokers, 3-aminobiphenyl was detected at low concentration. Adduct levels of 2-aminonaphthylene and orthotoluidine were not significantly different between the smoker and nonsmoker participants. Our study shows that 4-aminobiphenyl Hb adducts remain the preferred biomarker for identifying people exposed to aromatic amines from tobacco smoke.
Introduction
In humans, cigarette smoking is a risk factor for bladder cancer that is due at least in part to certain aromatic amines present in tobacco smoke (1) (2) (3) (4) (5) . Secondhand smoke (SHS) is composed mainly of a mixture of sidestream smoke (gases and particles generated from burning cigarettes between puffs) and exhaled mainstream smoke. The U.S. Environmental Protection Agency (EPA) designated passive smoking or SHS as a Class A carcinogen because SHS has been linked to a number of adverse health effects in exposed nonsmokers, including a potentially increased bladder cancer risk (4, (6) (7) (8) (9) (10) . The American Cancer Society estimated that, in 2009, there would be 70,980 new cases of and 14,330 deaths from bladder cancer in the U.S. The EPA uses a rating system similar to that of International Agency for Research on Cancer (IARC) to classify the cancer-causing potential of a substance as follows: Group A, carcinogenic to humans; Group B, likely to be carcinogenic to humans; Group C, suggestive evidence of carcinogenic potential; Group D, inadequate information to assess carcinogenic potential; and Group E, not likely to be carcinogenic to humans. The EPA has concluded that exposure to SHS can cause lung cancer in adults who do not smoke and has estimated that exposure to SHS causes approximately 3000 lung cancer deaths per year in nonsmokers. The EPA also found exposure to SHS has also been shown in a number of studies to increase the risk of heart disease, breast cancer, and respiratory illnesses. Historically, exposure to aromatic amines has been found in occupational settings such as chemical manufacturing and rubber industries (11) (12) (13) (14) . Subsequent to the release of these findings, the use of aromatic amines in many industrial settings has been substantially reduced or eliminated. However, the aluminum industry, for example, remains a source of exposure to carcinogenic arylamines, mainly polycyclic aromatic hydrocarbons, as does tobacco smoke (4, 8, 15) . Current consensus is that for humans, compounds such as amines, smoking, and SHS are regarded as the major exposure sources (4, 6, 8, 16, 17) .
Aromatic amines in tobacco smoke include aniline, orthotoluidine (o-TOL), 2-aminonapthylene (2-AMN), and both 3-(3-ABP) and 4-aminobiphenyl (4-ABP). Their concentration in the mainstream and sidestream smoke depends on the tobacco type, cigarette brands, and smoking topography (2, (18) (19) (20) (21) (22) . Aniline is the predominant aromatic amine in cigarette smoke, but it is less active in forming adducts and is a relatively ubiquitous compound in the environment. Consequently, despite the elevated aniline levels in tobacco smoke, concentrations measured in smokers and nonsmokers tend to be similar (23, 24) . This non-specificity precludes the use of aniline as a biomarker for tobacco smoke exposure. o-TOL and 2-AMN, which smokers are known to have at elevated levels, are also relatively prominent among aromatic amines in tobacco smoke, although they have limited specificity for tobacco exposure due to other occupational exposures (4, 8) . Conversely, 3-ABP and 4-ABP, although less concentrated in tobacco smoke, have few alternative environmental sources; they are, therefore, moderately specific for tobacco smoke exposure, making them the most potentially useful markers for this purpose (25, 26) .
4-ABP is known to form stable adducts with hemoglobin (Hb), especially on the β-chain cysteine 93 residue (24, 27) . Aromatic amines are metabolized mainly in the liver where they are N-glucuronidated or N-acetylated or form N-hydroxyarylamine via oxidation. Upon entering the blood stream, N-hydroxyarylamine is oxidized to nitroso form, which can form adducts with hemoglobin ( Figure 1 ). These adducts have proven useful in monitoring integrated exposures over several months (6, 16, 17, 23) . Unlike DNA adducts, no repair mechanisms have been identified for adducted hemoglobin. Once formed, the adducts are assumed to persist for about 120 days, the lifetime of the red cell (9, 17, 28) . In most cases, these adducts' persistence is an advantage. However, for monitoring short-term changes in exposure, adducts might be of limited use.
Several studies have measured tobacco-related aromatic amines (2, 3, 6, 17, 26, 29, 30) . In 1999, Doerge et al. (31) reported an assay for 4-ABP DNA adducts in dosed animals using highperformance liquid chromatography-electrospray mass spectrometry (HPLC-MS). Assays have also been reported using gas chromatography (GC)-MS for the non-tobacco-related 2-aminobiphenyl (32) and by either GC-electron capture detection (ECD) or LC-ECD for anilines and toluidines in human urine (10, 33) . For analysis of nonbiological fluids (e.g., air, tobacco smoke, or paints), several approaches have been used, including electrokinetic chromatography (34) , supercritical fluid extraction (35) , and GC-MS (36). Stabbert et al. (21) published the first GC-tandem mass spectrometry (MS-MS) application for the analysis of aromatic amines in tobacco smoke.
Among methods reported for analysis of 4-ABP adducts in biological fluids, most laboratories opted for GC-MS-negative ion chemical ionization (NICI) (26, (28) (29) (30) 37, 38) . In the method described here, however, when measuring human blood samples, positive electron ionization (EI) combined with MS-MS produced better sensitivity in part because of substantially lower background interference. Our method is also suitable for application to the analysis of samples from both smokers and nonsmokers. It improves on existing methods by requiring smaller sample volumes and shorter and simpler sample preparation procedures.
Experimental

Standards and reagents
Native and unlabeled 4-ABP was purchased from Aldrich (Milwaukee, WI), and the isotopically labeled 4-ABP-d 9 internal standard was obtained from Toronto Research Chemicals (Toronto, ON, Canada). Native and labeled o-TOL, 2-AMN, and 3-ABP were also purchased from Toronto Research Chemicals. High-purity hydrochloric acid, pentafluoropropionic acid anhydride (PFPA), and trimethylamine were also Aldrich products. Drabkins reagent kit and hemoglobin standard solution (20% mg cyanmethemoglobin) were purchased from Stanbio (Boerne, TX). Solvents were GC 2 grade except for water, which was HPLC grade. All solvents were purchased from Burdick and Jackson Labs (Suwanee, GA), and all gases were ultra-high purity grade. Solid-phase extraction (SPE) HLB ® (hydrophiliclipophilic balanced) and MCX ® (mixed-mode strong cation exchange) cartridges were purchased from Waters (Milford, MA). ChemElut ® liquid-liquid extraction and sodium sulfate cartridges were obtained from Varian (Walnut Creek, CA).
Samples
Two hundred whole blood samples were obtained from Tennessee Blood Services (Memphis, TN). Information on race, age, and self-reported smoking status was recorded by the company. However, actual smoking status was determined based on serum cotinine analysis of each sample. Donors were mostly male and African-American (88% of nonsmokers and 98% of smokers). Tennessee Blood Services is a commercial blood bank that seeks paid donors through advertisement. Because of the predominantly African-American demographic of its location, the donor pool has a high percentage of AfricanAmericans. There was no IRB requirement because all samples were received anonymously.
Instrumentation
Analyses were conducted with a ThermoScientific TSQ Quantum MS equipped with a Trace™ GC and the Xcalibur data system (ThermoScientific, San Jose, CA). The GC was equipped with a programmable temperature vaporization (PTV) injector. The on-column injection system incorporated a 0.52-mm by approximately 2.0-m deactivated fused silica retention gap connected to a J&W DB-1701 capillary column (0.25 mm × 30 m × 0.25-µm film thickness, Agilent, Santa Clara, CA). Total hemoglobin assays were conducted photometrically with a Beckman DU-7 spectrophotometer (Brea, CA). Concentration steps employed a Vacuum Evaporator Savant SpeedVac AES 200 equipped with a VP190 high vacuum pump, an RT 4104 refrigerated trap, and a VaporNet VN100 auxiliary trap (ThermoScientific/Savant Instruments, Farmingdale, NY).
Preparation of hemoglobin adduct samples
Extraction. Whole blood samples (1-2 mL) were centrifuged immediately after collection. The red blood cells were transferred to clean 10-mL cryo screw-cap tubes. The cells were washed three times with 5 mL of 0.9% physiological saline and, if further sample preparation could not be carried out immediately, stored at -70°C. Frozen samples were allowed to thaw and were then mixed well with 2.0 mL Burdick and Jackson water to form a 3-mL volume lysate. Two water blanks were added at this point. Toluene (0.5 mL) was added to remove free o-TOL, 2-AMN, 3-ABP, and 4-ABP, and the toluene layer was aspirated and discarded. We set aside 20 µL of extract or blank for hemoglobin analysis, and to each sample we added 10 µL of internal standard, followed by 200 µL of 10 M NaOH (freshly prepared and allowed to cool to room temperature before use). The samples were hydrolyzed for 3 h at room temperature with occasional mixing every 30 min. After hydrolysis, the samples were extracted with 6 mL of hexane and vortex mixed for 1.0 h. If an emulsion formed, it was broken up by freezing at -70°C for approximately 1-2 h. The hexane layer was then transferred and back-extracted with 1 mL 0.1 N HCl. The samples were further cleaned up using Waters MCX columns (30) .
Before processing on OASIS HLB or pre-cleaned ChemElut columns, the aqueous phase from the HCl back-extraction was neutralized with 10 M NaOH. HLB cartridges were pretreated with methanol and water, and the analytes were eluted with 2 mL of methylene chloride. ChemElut 1-mL cartridges were preconditioned with KOH followed by methylene chloride, and were oven-dried at 55°C before use. Analytes were eluted from ChemElute columns with 2 × 5 mL methylene chloride. In either case, the final eluant was dried in the Savant to approximately 300 µL residual volume.
Derivatization. Analytes were derivatized in methylene chloride to their pentafluoropropionates by adding 3 µL of 0.1 M trimethylamine followed by 2 µL of PFPA. Samples were mixed and allowed to stand at room temperature for 30 min. The solution was then evaporated in an amber vial with a 300-µL insert, and 5 µL of toluene was added to the residue. In most cases, samples were analyzed immediately. If necessary, however, at this point vials were sealed and stored at -70°C for several days before analysis.
Analysis by GC-MS-MS
The PTV injector was kept at 80°C, ramped up to 270°C at 14.5°C/s at injection, and maintained at 270°C for the entire GC run. The transfer line temperature was maintained at 270°C, and the ion source temperature was 280°C. A 2-µL aliquot of the derivatized sample in toluene was injected into the retention gap with an initial oven temperature of 80°C. The oven temperature was then immediately ramped to 180°C at a rate of 40°C/min, then to 270°C at a rate of 60°C/min, and held at the final temperature for 1.5 min. The helium carrier gas was maintained at a constant flow of 1.2 mL/min. The MS was operated in the EI positive-ion multiple-reaction-monitoring (MRM) mode with a scan time of 0.070 s. The collision gas was ultra-pure Argon at 1.2 mTorr, and the collision energy was 20-30 eV. Normal run times were about 6.5 min.
Calculation
For each analyte, we prepared calibration curves from the area ratios of the native and labeled compounds. We used 14 standards, ranging from 0.00 to 100 pg/µL, which we assayed in duplicated before each analytical series. The lowest nonzero standard was 0.05 pg/µL. In addition, to confirm instrument performance before and after each run, at least two standards were analyzed daily. Figure 2 shows a representative calibration curve for 4-ABP with excellent linearity over more than three orders of magnitude (R 2 = 0.9974).
Each run included 20 unknowns, 2 blanks, and 2 quality control (QC) pools (one high and one low) prepared from smokers and nonsmokers, respectively. Sample concentrations were calculated by comparing the ion ratios to the standard curve. Final reported concentrations were calculated by subtracting the value for the blank (if any) then normalizing to the hemoglobin concentration. If the blank exceeded 0.4 pg (oncolumn), runs were rejected. Runs were also rejected if any QC pool was outside of the three standard deviation limits for that pool or if both of the QC pools were outside of two standard deviation limits in the same direction. Quality assurance for these runs followed a complex, previously described (39), multi-rule algorithm implemented in SAS/QC.
Other analyses
Hb assay. Total Hb was determined using a Drabkins reagent kit. One Stanbio Drabkins reagent vial was reconstituted to 500 mL with deionized water and, if any insoluble particles remained, filtered. Twenty microliters of each lysate, including two water blanks and two QC pools, was added to corresponding test tubes containing 5.0 mL Drabkins reagent, vortex mixed, and set aside at room temperature for 15 min. The absorbance was measured in a Beckman UV-Vis spectrophotometer at 540 nm, using 10-mm path length square disposable cuvettes. The Hb concentration was calculated using an Hb calibration curve after subtracting the reagent blank from each sample and then multiplying by the total lysate sample volume (3.0 mL).
Cotinine assay. Serum cotinine measurements were made according to a previously reported method, utilizing HPLC-atmospheric pressure ionization (APCI)-MS-MS (40) . Briefly, serum samples were spiked with trideuterated cotinine as an internal standard, extracted with methlylene chloride, and analyzed by HPLC-APCI-MS-MS.
Results
Analytes were quantified by positive GC-EI-MS-MS using the MRM mode. Figure 3 shows a total ion chromatogram of the four analytes monitored in a human blood sample. The chromatogram reveals a total baseline separation of 3-ABP and 4-ABP with a total run time of only 6.5 min. Quantification results were calculated using standard calibration curves. Standards were prepared using free aromatic amines ranging from 0.00 to 100 pg/µL. The total on-column limits of detection (LOD) for o-TOL, 2-AMN, 3-ABP, and 4-APB were 0.23, 0.39, 0.30, and 0.24 pg, respectively. These LODs were estimated using standard deviation of calibration curves (n = 6). The effective working LOD was, however, estimated at approximately 5.22 pg/g Hb for 4-ABP and 18.73 pg/g Hb for 2-AMN using a dilution of low QC samples prepared from nonsmoker samples. Because of background interference observed in the internal standard 2-AMN-d 7 mass spectrum, the LOD for 2-AMN was relatively high.
To select the best conditions for extraction, evaluations of different SPE and liquid-liquid cartridges were made, and the results shown in Figure 4 . The highest sensitivity was achieved with the MCX cartridges. However, because of residual water in the NH 4 OH, this approach also had the longest drying time, approximately 1.0-1.5 h ( Figure 4A ). Extracts from HLB columns used in conjunction with a Na 2 SO 4 cartridge to eliminate water residues dried completely in 15 min but resulted in a higher background level ( Figure 4B ). Without Na 2 SO 4 cartridges, the background is similar to that of the MCX, but again, the drying time was more than 2 h. The recovery was also lower than that of the MCX column. Liquid-liquid extraction using a ChemElut cartridge resulted in acceptable sensitivity, though the recovery was less than that observed with MCX, which was chosen as our final approach. Unless indicated otherwise, all results reported were obtained using MCX cartridges. product ion of the native unlabeled 4-ABP is 168, which represents a loss of PFP from the pentafluoropropionic derivative, and 177, which represents a similar loss from the deuterated ion. Consequently, the presence of native 4-ABP was monitored by the m/z 315 → 168 ion transition and m/z 324 → 177 for the corresponding deuterated internal standard, and the area ratio of the two signals was used in the quantification. 3-ABP, an isomer of 4-ABP, that is also associated with tobacco smoke exposure, has a similar fragmentation pattern, but with different base peaks of 153 and 162 for the native and deuterated compounds, respectively. PTV pseudo on-column injection mode offered the best peak shapes and sensitivity in comparison to either regular PTV or split-splitless (SSL) injection modes ( Figure 5 ). Significant tailing of all analytes occurred in the SSL and PTV/splitless mode. Excellent symmetrical peak shapes were obtained using the PTV pseudo on-column injection, keeping all other injection parameters the same, as in the other two injection modes. The sharper peak shapes observed with PTV pseudo on-column analysis probably resulted from the refocusing effect of a pre-column, given that peak shape improved in concert with the pre-column length.
To ensure method performance, we used analysis of QC pools to assess long-term stability and present assay sensitivity. The results acquired during a three-month period showed that throughout the three months, the adduct levels in the QC pool samples did not indicate a significant positive or negative trend. This was in agreement with both analyte and method stability during that time. Figure 6 shows the distribution of 4-ABP adduct levels in a sample of 193 predominately African-Americans, including both smokers and nonsmokers. The distribution is not a bimodal distribution for nonsmokers and smokers as we had expected. It is instead a continuous distribution among nonsmokers from smokers. Corresponding serum cotinine concentrations were obtained for all of these subjects. Among the 100 smokers in this group, defined as having serum cotinine values greater than 10 ng/mL (41), the mean (95% CI) concentration of adducts was 75.8 pg/g Hb (66.5 to 86.5). Among the 93 nonsmokers, the mean 4-ABP adduct level was significantly lower, at 29.9 pg/g Hb (24.7 to 36.2). The actual best estimated concentrations of three nonsmoker samples were used in our calculation, although the values were below the LOD.
Serum cotinine concentrations greater than 10 ng/mL are presumed to represent active users of tobacco, whereas lower serum cotinine values likely represent nonsmokers with varying exposure to ETS. For these smokers and nonsmokers, Figure 7 shows a correlation between 4-ABP adducts and serum cotinine levels. The correlation is not strong (r = 0.496) and among the studied population has a high degree of variability. Table II lists the mean concentrations of two of the analytes with their 95% CI. Values for 3-ABP were not summarized because all nonsmokers and 82% of smoker samples were not detectable.
Discussion
Our initial efforts to develop assays for hemoglobin adducted 4-ABP were based on a previous method reported by Tannenbaum et al. (17) that required 10 mL of whole blood and relatively time-consuming dialysis, extraction, and cleanup procedures. These issues limited that method's application in large epidemiological studies. In revising the method, various experimental parameters were examined in an effort to combine the highest analyte recovery with the shortest possible sample preparation time. The lysed hemoglobin solution was extracted with toluene to remove free o-TOL, 2-AMN, 3-ABP, and 4-ABP (30) . This toluene extraction replaced the 24-h dialysis (26) and reduced preparation time considerably. The extracted samples were hydrolyzed in 10 M NaOH for 3 h; for our analysis, a single hexane extraction (6 mL) was sufficient. SPE using MCX 3-cc cartridges and MS-MS allowed us to work with smaller sample volumes, 1-2 mL instead of 10 mL whole blood (26, 30) . This substantial reduction in required sample volume is particularly important for support of large studies and for improved analysis of children's samples. In subsequent GC-MS-MS analysis, the preconcentration step (to approximately 300 µL) before pentafluoropropionate derivatization increased the conversion efficiency and, therefore, increased analyte detection sensitivity. For this analysis, we initially used negative ion chemical ionization because of literature reports indicating its high sensitivity. Although NICI provided excellent sensitivity with pure standards, we found that EI-MS-MS provided better sensitivity when analyzing human extracts, presumably resulting from less background interference.
Our samples were predominately from African-Americans (88% of the nonsmokers and 98% of the smokers), and the majority were male (70% nonsmokers and 80% smokers). As has been noted in several previous studies (1, 6, 17, 37, (42) (43) (44) , hemoglobin adducted 4-ABP levels are significantly higher among smokers. In this population, the smokers mean concentration was approximately two times greater compared with nonsmokers (75.8 pg/g Hb vs. 29.9 pg/g Hb). This significant difference is expected because in cigarette smoke the level of 4-ABP is known to be very high. Our study confirms that cigarette smoke is highly correlated with the level of 4-ABP Hb adducts, and our results confirm that 4-ABP Hb adducts can be used as a reliable biomarker for tobacco exposure. We note that our results are lower than in several previous studies, which reported a 3-4-fold difference between smokers and nonsmokers (23, (44) (45) (46) . Yet in these studies, the average number of cigarettes smoked per day was 20-40. The average number of cigarettes smoked per day for our smokers was 10, and our results are consistent with other studies of smokers in which the number of cigarette smoked per day was 5-15 (2, 9, 45, 47, 48) . In our study, 3-ABP was detected in approximately 15% of the smoker samples and was not detected in all nonsmokers. These results are in agreement with Sakar et al. (26) , who detected 3-ABP Hb adducts in smokers only, ranging from 0.00 to 10.41 pg/g Hb. 3-ABP may be more specific to tobacco exposure, but it is not always detectable in smokers, and it is less toxic than 4-ABP (26, 49) . For this studied population, the concentrations of o-TOL and 2-AMN between smokers and nonsmokers were not significantly different, and this group showed a high degree of adduct level variability, possibly due to differences in occupational exposure and acetylation phenotypes (13, 14) .
Detectable levels of Hb adducts of 4-ABP in nonsmokers have been attributed to possible dietary contamination as well as occupational exposures and air pollution (7, 14, 36, 50, 51) . Exposure to SHS is, however, likely an important factor contributing to increasing levels of various aromatic amines in humans (2, 3, 6, 9, 52, 53) and in human fetuses (37) . In fact, in sidestream relative to mainstream tobacco smoke, many aromatic amines including 4-ABP are enriched several fold. Consequently, ETS has now been classified as a class A carcinogen and a potential risk factor for bladder cancer. In 2006, California declared ETS a toxic air contaminant. Recently, we conducted a study of controlled SHS exposure of nonsmokers to determine whether an increase in hemoglobin adducts of aromatic amines could be directly demonstrated following brief exposure to sidestream smoke. After a 4-h exposure to sidestream smoke under controlled conditions, the study results confirmed a small but statistically significant increase in the concentration of 4-ABP Hb adducts (54) .
In this study's subjects, a significant association was also found between 4-ABP adducts and total serum cotinine levels ( Figure 7 ; r = 0.496; p < 0.0001; n = 193). However, within the smoker and nonsmoker groups, the distribution of adduct levels shows a high degree of variability. Such differences might be attributed to various factors, including frequency and number of cigarettes smoked per day (1) (2) (3) 5, 42) , difference in cigarette brands (1,22,42,43,55) , and smoking topography (2, 19, 22, 56) among the active smokers. Moreover, differences in adduct levels are likely to be dependent on individual differences in metabolism (e.g., in acetylation phenotypes) (5, 7, 42, 43, 57) .
In conclusion, for this studied population the concentrations of o-TOL and 2-AMN were not significantly different between smokers and nonsmokers. 3-ABP was detected in approximately 15% of the smoker samples in this study and was not detected in all nonsmokers. 3-ABP may be more specific to tobacco exposure, but it is not always detectable in smokers and is less toxic than 4-ABP (26, 49) . By contrast, 4-ABP Hb adduct levels were significantly different between smokers and nonsmokers and correlated well with total serum cotinine levels.
Thus, for identifying people exposed to aromatic amines from tobacco smoke, 4-ABP Hb adducts remain the preferred biomarker.
